Management of Cheyne-Stokes Respiration in Neurological Conditions

Immediate Assessment and Monitoring

The American Heart Association recommends monitoring oxygen saturation continuously with pulse oximetry, targeting SpO2 ≥92-95% in patients with Cheyne-Stokes respiration (CSR) due to neurological conditions, particularly acute stroke 1, 2
The American Stroke Association recognizes that CSR occurs frequently after stroke and causes oxygen desaturation that can worsen neurological injury, and recommends administering supplemental oxygen when hypoxia is documented by pulse oximetry or blood gas determination 1, 2, 3

The American College of Cardiology recommends elevating the head of bed 15-30° in patients with CSR due to neurological conditions, particularly those with risk of airway obstruction or aspiration, decreased level of consciousness, brain stem dysfunction, or suspected elevated intracranial pressure 1, 3

The American Heart Association considers endotracheal intubation if the airway is threatened, particularly in patients with decreased consciousness or brain stem stroke who have impaired oropharyngeal mobility and loss of protective reflexes 1, 2, 3
The American College of Chest Physicians notes that approximately 50% of stroke patients requiring intubation die within 30 days, but airway protection prevents aspiration pneumonia—a leading cause of post-stroke death 2, 3

The American Thoracic Society recommends providing oxygen only when indicated by pulse oximetry showing desaturation, blood gas determination confirming hypoxia, or clinical evidence of respiratory compromise 1, 2, 3
The American College of Cardiology advises against routine administration of supplemental oxygen at 3 L/min to all stroke patients, as controlled trials show no benefit in normoxic patients 2, 3

The American Academy of Sleep Medicine recommends avoiding sedative medications and central nervous system depressants, such as opiates, benzodiazepines, and other agents that depress upper airway tone, as they worsen hypoventilation and can further depress respiratory drive in patients with CSR 4, 5, 6

The American College of Cardiology recommends optimizing cardiac function medically if CSR is associated with congestive heart failure, as this may improve breathing abnormalities 6
The American Heart Association notes that CPAP is not recommended as first-line treatment for CSR in heart failure patients, as randomized trials suggest increased mortality in the first 2 years 6

The American Stroke Association advises against delaying stroke treatment to address CSR—manage oxygenation and ventilation while proceeding with acute stroke protocols 1
The American Thoracic Society recognizes that continuous monitoring is essential because patients with CSR may experience profound hypoxemia before physiologic compromise is clinically detected 4, 5

The American College of Chest Physicians recommends positive pressure ventilation via tracheostomy for patients with chronic neurological conditions requiring ongoing ventilatory support, to ensure optimal oxygenation 4, 5
The American Society of Anesthesiologists advises against performing tracheostomy in the acute setting with intracranial hypertension (ICP >15 mmHg) or severe hypoxemia (PaO2/FiO2 <100 mmHg) 7